Literature DB >> 32621311

Update on high-power short-duration ablation for pulmonary vein isolation.

Jie Qiu1, Yan Wang1, Dao Wen Wang1, Mei Hu2, Guangzhi Chen1.   

Abstract

Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. However, this procedure remains complex and time-consuming, and the recurrence of AF after PVI is still unsatisfactory. Current technologies have improved our knowledge of the association between radiofrequency lesion creation and ablation parameters (power and duration), which triggered the development of high-power short-duration (HPSD). During the past decade, several preclinical and clinical studies have been conducted to confirm the feasibility, safety, and outcome of PVI ablation with HPSD or very high-power short-duration (vHPSD) settings, which increased electrophysiologists' interests in the utility of HPSD strategies. This paper describes the theoretical basis and recent research findings of HPSD or vHPSD ablation and summarizes the state-of-the-art evidence behind the role of this strategy in PVI.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  atrial fibrillation; high-power short-duration; pulmonary vein isolation

Mesh:

Year:  2020        PMID: 32621311     DOI: 10.1111/jce.14649

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  [Ablation of a para-Hisian accessory pathway with high-power short-duration].

Authors:  Christian Spies; Martin Neef
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-01-15

2.  JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

Authors:  Akihiko Nogami; Takashi Kurita; Kengo Kusano; Masahiko Goya; Morio Shoda; Hiroshi Tada; Shigeto Naito; Teiichi Yamane; Masaomi Kimura; Tsuyoshi Shiga; Kyoko Soejima; Takashi Noda; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura; Shun Kohsaka; Hideo Mitamura
Journal:  J Arrhythm       Date:  2022-01-07

Review 3.  Comparison of Effectiveness and Safety between High-Power Short-Duration Ablation and Conventional Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Shuyu Jin; Lu Fu; Junrong Jiang; Xingdong Ye; Huiyi Liu; Yanlin Chen; Sijia Pu; Shulin Wu; Yumei Xue
Journal:  J Interv Cardiol       Date:  2022-08-16       Impact factor: 1.776

4.  A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives.

Authors:  Allyson L Varley; Omar Kreidieh; Brigham E Godfrey; Carolyn Whitmire; Susan Thorington; Benjamin D'Souza; Steven Kang; Shrinivas Hebsur; Bipin K Ravindran; Edwin Zishiri; Brett Gidney; Matthew B Sellers; David Singh; Tariq Salam; Mark Metzl; Alex Ro; Jose Nazari; Westby G Fisher; Alexandru Costea; Anthony Magnano; Saumil Oza; Gustavo Morales; Anil Rajendra; Joshua Silverstein; Paul C Zei; Jose Osorio
Journal:  J Interv Card Electrophysiol       Date:  2021-07-02       Impact factor: 1.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.